Page last updated: 2024-09-04

irofulven and calixarenes

irofulven has been researched along with calixarenes in 1 studies

Compound Research Comparison

Studies (irofulven)	Trials (irofulven)	Recent Studies (post-2010) (irofulven)	Studies (calixarenes)	Trials (calixarenes)	Recent Studies (post-2010) (calixarenes)
99	22	7	1,903	0	1,088

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dings, RP; Griffin, RJ; MacDonald, JR; Mayo, KH; Van Laar, ES; Waters, SJ; Webber, J; Zhang, Y	1

Other Studies

1 other study(ies) available for irofulven and calixarenes

Article	Year
Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven. Cancer letters, 2008, Jul-08, Volume: 265, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Calixarenes; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice; Ovarian Neoplasms; Peptides; Proteins; Sesquiterpenes; Xenograft Model Antitumor Assays	2008

Article

Year

Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven.

Cancer letters, 2008, Jul-08, Volume: 265, Issue:2

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Calixarenes; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice; Ovarian Neoplasms; Peptides; Proteins; Sesquiterpenes; Xenograft Model Antitumor Assays

2008